| List of Cases |
Project Finance
Management |
|
|
|
|
|
Presentations
submission timeliness, slide quality, oratorical art, audience involvement in
the case study 0-3 |
The complexity of
the analyzed problem 0-3 |
Case studies
breadth, i.e. quite a lot of work done 0-4 |
Depth of the case
analysis, i.e. use sophisticated analytical techniques 0-4 |
It was collected an
additional, interesting and valuable material on the Internet 0-2 |
A summary of the
findings, what is memorable, the most valuable of the case presented, where
you can apply the acquired knowledge 0-2 |
Working as opponent of the peer
presentations or active participation in the cases analysis 0-1. Good questions or comments prized pluses,
3-4 pluses equal to 1 point. |
|
|
|
|
|
|
|
|
|
|
| # |
Page |
Case |
The names
of students who analyzed the case |
Date of
presentation |
Presentations
queue |
Slides of
the presentation |
Additional
material 1 |
Additional
material 2 |
Assessment of
case study |
| 1 |
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 2 |
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 3 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Aytan Namazli |
|
|
|
|
|
9 |
3 |
3 |
2 |
|
|
|
1 |
| 4 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Sinan Yüksek |
|
|
|
|
|
8 |
3 |
3 |
2 |
|
|
|
|
| |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Yamancan |
|
|
|
|
|
8 |
3 |
3 |
2 |
|
|
|
|
| 5 |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 6 |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 7 |
381-394 |
The Super Project |
Oleg Bogomolov |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 8 |
381-394 |
The Super project |
Hamzat Adeshina |
|
|
|
|
|
8 |
2 |
3 |
2 |
|
|
1 |
|
| |
381-394 |
The Super project |
Siddiqqi Shamsulhoda |
|
|
|
|
|
9 |
2 |
3 |
2 |
|
|
1 |
1 |
| 9 |
395-403 |
Net Flix |
Arunas Kalkys |
|
|
|
|
|
10 |
3 |
3 |
2 |
|
1 |
1 |
|
| 10 |
395-403 |
Net Flix |
Yuliia Halan |
|
|
|
|
|
11 |
3 |
3 |
2 |
|
1 |
1 |
1 |
| |
395-403 |
Net Flix |
Olesia Ščerba |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 11 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
Asta Misiutė |
|
|
|
|
|
11 |
3 |
3 |
2 |
|
1 |
1 |
1 |
| 12 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
Silvija Berštautienė |
|
|
|
|
|
10 |
3 |
3 |
2 |
|
1 |
1 |
|
| |
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 13 |
419-423 |
Ocean Carriers |
Emilija Paurytė |
2017.12.15 |
1 |
|
|
|
9 |
3 |
3 |
2 |
|
|
1 |
|
| 14 |
419-423 |
Ocean Carriers |
Arūnas Rakauskas |
2017.12.15 |
1 |
|
|
|
9 |
3 |
3 |
2 |
|
|
1 |
|
| |
419-423 |
Ocean Carriers |
Mantvydas Masilevicius |
2017.12.15 |
1 |
|
|
|
10 |
3 |
3 |
2 |
|
|
1 |
1 |
| 15 |
405-418 |
Whirlpool Europe |
Žygimantas Račkys |
|
|
|
|
|
10 |
3 |
3 |
2 |
|
1 |
1 |
|
| 16 |
405-418 |
Whirlpool Europe |
Kotryna Dyburytė |
|
|
|
|
|
10 |
3 |
3 |
2 |
|
1 |
1 |
|
| |
405-418 |
Whirlpool Europe |
Matas Rutkauskas |
|
|
|
|
|
10 |
3 |
3 |
2 |
|
1 |
1 |
|
| 17 |
431-434 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 18 |
431-435 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 19 |
431-436 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 20 |
431-437 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 21 |
431-438 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 22 |
431-439 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 23 |
431-440 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 24 |
431-441 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| 25 |
431-442 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| |
431-443 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
| |
431-444 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|